Novocure
Price & Volume
Stats
See moreOpen | $16.13 |
Previous Close | $16.59 |
Day Range | $16.13-$16.92 |
52W Range | $10.87-$24.73 |
Market Cap | $1.7B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $577.7M |
Revenue Growth (YoY) | 21.8% |
Gross Profit (12 Mos) | $423.5M |
Diluted EPS | -$1.39 |
News
See moreYahoo Finance • 21 days ago
FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer
Yahoo Finance • 4 months ago
Novocure to Report Second Quarter 2024 Financial Results
Yahoo Finance • 5 months ago
METIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free Survival
Yahoo Finance • 5 months ago
TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in Germany
About
CEO | Mr. Asaf Danziger |
Address | No. 4 The Forum, Saint Helier, Jersey, JE2 4UF |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 1,453 |
